Over-expression of Rac1 and Rac3 GTPases has been noted in several small cohorts of breast cancers [16-18] and it has been suggested that they may have a role in resistance to endocrine treatment [19, 20]. This evidence concerns the gene RAC1 and breast carcinoma.